March 2015

Emerging Concepts Are Shaping the Future of Retina

Allen C. Ho, MD, and Robert L. Avery, MD

Retina News

Health Care Reform: How Are We Doing?

Although by some measures the PPACA has improved the state of US health insurance, other indices show downward trends in efficacy and increases in care.

George A. Williams, MD

Funding Strategies for a Retina Program

Aron Shapiro; Matt Chapin; and Sena Biswas, PhD

Maximize Your Final Six Months Of Fellowship

S. K. Steven Houston III, MD

Optimizing Reimbursement in the Face of Medicare's Payment Cuts

Changes in the Medicare Fee Schedule mean physicians must adjust their billing practices to optimize reimbursements and prevent audits.

Riva Lee Asbell

Surgical Pearls for Pediatric Patients

PCL and Preoperative Anti-VEGF Use for Membrane Dissection in Diabetic TRD

Intravitreal bevacizumab used prior to en bloc perfluorodissection may yield improved anatomic and functional improvement in some cases.

J. Fernando Arevalo, MD, FACS

Find Melanoma Early, Save a Life

The challenge is to identify small melanoma using known clinical risk factors.

Roberta Chiu, MBA; Jarin Saktanasate, MD; and Carol L. Shields, MD

Widefield Imaging in Pediatric Retinal Disease

Widefield imaging can detect peripheral pathology not typically seen with standard imaging, often before patients are symptomatic.

Antonio Capone Jr, MD; Ankoor Shah, MD; Ashkan Abbey, MD; Kimberly Drenser, MD, PhD; and Michael Trese, MD

Reducing the Deficit in Screening and Treatment for Infants at Risk for ROP

Thomas C. Lee, MD

Gene Therapy for Treatment of Retinal Disease

Lauren S. Taney, MD, and Elias Reichel, MD

Update on Gene Therapy for the Treatment of Retinal Diseases

Gene therapy can correct underlying genetic defects that cause disease, potentially with lifelong clinical benefits based on a single therapeutic administration.

Mark E. Pennesi, MD, PhD

Gene Therapy: The Future of Ophthalmology?

An Interview with Thomas W. Chalberg, PhD, and Samuel B. Barone, MD

The Next Generation of Artificial Vision

Current technologies, although remarkable in their abilities to restore function, are only the first steps in curing blindness.

Paul Hahn, MD, PhD

The Trajectory of Innovation in Retinal Implants

Subretinal implants are now a clinical reality for restoring vision in patients blinded by RP.

Helmut Sachs, MD

Overview of Sustained-Release Drug-Delivery Systems

A novel technique may avoid some of the limitations of current preparation methods.

Nikita Malavia, PhD, and Peter K. Kaiser, MD

5 Questions With Nikolas J. S. London, MD

Nikolas J. S. London, MD, is a vitreoretinal surgeon at Retina Consultants of San Diego.